Who
David R. Epstein
Director
Company insider
Files Form 4 as: Director, AgomAb Therapeutics NV; Director, Tempus AI; CEO, Seagen; Director, Senti Biosciences Holdings; Director, Evelo Biosciences; Director, Axcella Health; Director, Rubius Therapeutics; Director, International Flavors & Fragrances.
In numbers
- Trades disclosed
- 210
- Buys
- 31
- Sells
- 20
- Bought
- $1.2M
- Sold
- $4.5M
- Companies
- 9
- Companies where not an officer
- 8
- First trade
- 22 Sep 2008
- Last trade
- 21 Oct 2026
- Last filed
- 22 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Oct 2026filed 22 Oct 2026 | AGMB AgomAb Therapeutics NVBiotechnology | SEC FORM 4 Bought | $44K5,000 at $8.86 | filing |
| 21 Oct 2026filed 22 Oct 2026 | AGMB AgomAb Therapeutics NVBiotechnology | SEC FORM 4 Bought | $45K5,000 at $8.90 | filing |
| 8 Oct 2026filed 9 Oct 2026 | AGMB AgomAb Therapeutics NVBiotechnology | SEC FORM 4 Bought | $45K5,000 at $8.90 | filing |
| 6 Oct 2026filed 7 Oct 2026 | AGMB AgomAb Therapeutics NVBiotechnology | SEC FORM 4 Bought | $44K5,000 at $8.70 | filing |
| 5 Oct 2026filed 7 Oct 2026 | AGMB AgomAb Therapeutics NVBiotechnology | SEC FORM 4 Bought | $43K5,000 at $8.57 | filing |
| 1 Sep 2026filed 3 Sep 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $16K250 at $65.55 | filing |
| 1 Sep 2026filed 3 Sep 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $16K250 at $65.55 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $16K370 at $43.40 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $16K370 at $43.40 | filing |
| 1 Jun 2026filed 3 Jun 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $12K250 at $49.40 | filing |
| 1 Jun 2026filed 3 Jun 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $12K250 at $49.40 | filing |
| 21 May 2026filed 26 May 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Code A | —5,913 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Code A | —5,913 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $13K250 at $50.69 | filing |
| 2 Mar 2026filed 4 Mar 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $13K250 at $50.69 | filing |
| 2 Feb 2026filed 4 Feb 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $22K370 at $59.41 | filing |
| 2 Feb 2026filed 4 Feb 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $22K370 at $59.41 | filing |
| 1 Dec 2025filed 3 Dec 2025 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $19K250 at $75.55 | filing |
| 3 Nov 2025filed 5 Nov 2025 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $33K370 at $90.00 | filing |
| 2 Sep 2025filed 4 Sep 2025 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Sold | $18K250 at $73.64 | filing |
News
Insider Buying: AgomAb Therapeutics (NASDAQ:AGMB) Director Purchases 10,000 Shares of Company StockAGMB · dailypolitical.com · 22 Oct 2026Tempus AI (NASDAQ:TEM) Stock Gets Price Target Bump from JPMorgan Chase & Co.TEM · dailypolitical.com · 14 Oct 2026Analyzing 111 (NASDAQ:YI) & Tempus AI (NASDAQ:TEM)TEM · themarketsdaily.com · 13 Oct 2026Tempus AI (NASDAQ:TEM) Stock Price Target Raised at Canaccord Genuity GroupTEM · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name David R. Epstein; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.